News

Why Shares of Pfizer Soared Today
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain.
Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...
Buy Pfizer Stock At $24?
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
Fierce Pharma6h
Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff threats close in
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...
Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand
CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...
Pfizer beats in Q2 earnings, reaffirms 2025 outlook
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...